Convenience Kit Recall: ACS Removes Kits with Faulty Namic RA Syringes

What sparked the recall?

American Contract Systems (ACS) announced a voluntary recall of its Convenience Kits that contain Namic RA syringes. The recall was triggered after the Food and Drug Administration (FDA) received reports of needle detachment during routine use, creating a risk of injury and compromised medication delivery.

Who is affected?

The recall applies to:

• All ACS Convenience Kits distributed in the United States from January 1 2024 to March 15 2024.
• Each kit includes one Namic RA syringe, a pre‑filled medication vial, and a sterile swab.

If you purchased or received a kit within this window, you should stop using it immediately.

How to identify a recalled kit

Look for the following markings on the packaging:

1. Batch number: CN‑2024‑01 to CN‑2024‑18.
2. Expiration date: any date after March 2024.
3. Label warning: “Recall – Do Not Use – ACS.”

When in doubt, scan the QR code on the box; it links to ACS’s recall verification site.

Steps to take if you have a recalled kit

• Stop using the product right away.
• Contact ACS customer support at 1‑800‑555‑0199 or visit acsrecall.com.
• Provide the batch number and purchase details.
• Choose a replacement (new Convenience Kit) or request a full refund.
• Dispose of the recalled kit according to the instructions on the website—place it in a puncture‑proof container and follow local medical waste guidelines.

Why the needle detachment matters

The Namic RA syringe is designed for precise sub‑cutaneous injection. A loose needle can:

• Cause tissue damage or bruising.
• Lead to under‑dosing, reducing treatment efficacy.
• Increase the risk of infection if the needle contaminates the injection site.

These safety concerns prompted ACS to act quickly and cooperate fully with the FDA.

What ACS is doing to prevent future issues

American Contract Systems has committed to a three‑phase improvement plan:

1. Enhanced Quality Control: Additional inspection steps for needle attachment during manufacturing.
2. Supplier Audits: A full review of the component supplier responsible for the syringe barrel.
3. Post‑market Surveillance: Real‑time monitoring of adverse event reports using a new digital tracking system.

These measures aim to restore confidence and ensure that similar defects do not recur.

Key takeaways for healthcare professionals

• Verify batch numbers before administering any medication from a Convenience Kit.
• Educate patients on how to recognize recall labels and what to do if they have an affected product.
• Keep a log of recalled kits and document the disposal process for compliance audits.

Conclusion

The ACS Convenience Kit recall highlights the importance of vigilant product monitoring and swift consumer communication. By following the steps above, patients and providers can minimize risk while awaiting replacement kits. Stay informed, check your kit’s batch number, and contact ACS for a hassle‑free swap.